72.11.Z - Scientific research and development activities
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.51.Z - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
62.01.Z - Activities related to programming, IT consulting, and related activities
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.10.Z - Head office activities
82.11.Z - Office administrative support activities and other business support services
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 10,5 | 0,6 | -3,7 | -690,4 |
EBITDA | 11,7 | 1,7 | -2,9 | -263,8 |
Short time liabilities | 1,9 | 0,9 | 0,4 | -52 |
Equity capital | 21,5 | 18,7 | 15 | -19,9 |
Operating profit (EBIT) | 10,6 | 0,2 | -4,2 | -2177,5 |
Assets | 25 | 19,8 | 15,5 | -21,6 |
Net profit (loss) | 8,8 | 0,5 | -3,7 | -874,9 |
Cash | 14,2 | 11,2 | 7 | -37,3 |
Net income from sale | 23,2 | 10,6 | 2,4 | -77,4 |
Liabilities and provisions for liabilities | 3,5 | 1,1 | 0,5 | -51 |
Working assets | 17,4 | 12,6 | 9 | -28,5 |
Depreciation | 1,2 | 1,5 | 1,4 | -12,4 |
% | % | % | p.p. | |
Profitability of capital | 40,8 | 2,6 | -24,8 | -27,4 |
Equity capital to total assets | 86,1 | 94,5 | 96,6 | 2,1 |
Gross profit margin | 45,4 | 6 | -155,4 | -161,4 |
EBITDA Margin | 50,6 | 16,5 | -119,6 | -136,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 31 | 66 | 35 |
Current financial liquidity indicator | 5.394740581512451 | 14.103931427001953 | 20.833995819091797 | 6,7 |
Net dept to EBITDA | -1.2003207206726074 | -6.32956075668335 | 2.422372341156006 | 8,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane